首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Optimized procedures for producing biologically active chemokines
Authors:Quinn Lu  Matthew C Burns  Patrick J McDevitt  Taylor L Graham  Abby J Sukman  James A Fornwald  Xiaoyan Tang  Kathleen T Gallagher  Gerald E Hunsberger  James J Foley  Dulcie B Schmidt  John J Kerrigan  Tia S Lewis  Robert S Ames  Kyung O Johanson
Institution:aGlaxoSmithKline, Biological Reagents & Assay Development, Mail Code: UE0548, 709 Swedeland Road, King of Prussia, PA 19406, USA;bGlaxoSmithKline, Discovery Technology Group, King of Prussia, PA 19406, USA;cGlaxoSmithKline, Respiratory Center of Excellence for Drug Discovery, King of Prussia, PA 19406, USA
Abstract:We describe here two strategies to produce biologically active chemokines with authentic N-terminal amino acid residues. The first involves producing the target chemokine with an N-terminal 6×His-SUMO tag in Escherichia coli as inclusion bodies. The fusion protein is solubilized and purified with Ni–NTA–agarose in denaturing reagents. This is further followed by tag removal and refolding in a redox refolding buffer. The second approach involves expressing the target chemokine with an N-terminal 6×His-Trx-SUMO tag in an engineered E. coli strain that facilitates formation of disulfide bonds in the cytoplasm. Following purification of the fusion protein via Ni–NTA and tag removal, the target chemokine is refolded without redox buffer and purified by reverse phase chromatography. Using the procedures, we have produced more than 15 biologically active chemokines, with a yield of up to 15 mg/L.
Keywords:Seamless cloning  SUMO hydrolase  Affinity purification  Disulfide bond formation in Escherichia coli  Protein refolding
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号